Merlin L. Robb

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ An Analysis of Transformations 1964 George E. P. Box
David R. Cox
1
+ PDF Chat Emerging Filoviral Disease in Uganda: Proposed Explanations and Research Directions 2014 Jonathan A. Polonsky
Joseph Francis Wamala
Hilde De Clerck
Michel Van Herp
Armand Sprecher
Klaudia Porten
Trevor Shoemaker
1
+ PDF Chat Evaluation of Locally Established Reference Intervals for Hematology and Biochemistry Parameters in Western Kenya 2015 Collins Odhiambo
Boaz Oyaro
Richard Odipo
Fredrick Otieno
George Alemnji
John Williamson
Clement Zeh
1
+ An appraisal of statistical procedures used in derivation of reference intervals 2010 Kiyoshi Ichihara
James C. Boyd
1
+ PDF Chat High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon 2010 Pierre Becquart
Nadia Wauquier
Tanel MahlakÔiv
Dieudonné Nkoghe
Cindy Padilla
Marc Souris
Benjamin Ollomo
Jean‐Paul Gonzalez
Xavier de Lamballerie
Mirdad Kazanji
1
+ PDF Chat CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa 2009 Etienne Karita
Nzeera Ketter
Matthew A. Price
Kayitesi Kayitenkore
Pontiano Kaleebu
Annet Nanvubya
Omu Anzala
Walter Jaoko
Gaudensia Mutua
Eugene Ruzagira
1
+ PDF Chat A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks 2016 Georgi Shukarev
BenoĂźt Callendret
Kerstin LĂŒhn
Macaya Douoguih
1
+ PDF Chat Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 2018 Angela Huttner
Sélidji Todagbé Agnandji
Christophe Combescure
José F. Fernandes
Emmanuel B. Bache
Lumeka Kabwende
Francis M. Ndungu
Jessica S. Brosnahan
Thomas P. Monath
Barbara LemaĂźtre
1
+ PDF Chat Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study 2019 Peter Halfmann
Amie J. Eisfeld
Tokiko Watanabe
Tadashi Maemura
Makoto Yamashita
Satoshi Fukuyama
Tammy Armbrust
Isaiah Rozich
Alhaji U. N’jai
Gabriele Neumann
1
+ Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation 2019 Sam Tozay
William A. Fischer
David A. Wohl
Kayla W. Kilpatrick
Fei Zou
Edwina Reeves
Korto Pewu
Jean DeMarco
Amy James Loftis
Katie King
1
+ PDF Chat Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses 2019 Bronwyn M. Gunn
Vicky Roy
Marcus M. Karim
Jessica N. Hartnett
Todd J. Suscovich
Augustine Goba
Mambu Momoh
John Demby Sandi
Lansana Kanneh
Kristian G. Andersen
1
+ Extraordinary diseases require extraordinary solutions 2020 Stanley A. Plotkin
Arthur L. Caplan
1
+ PDF Chat Long-lasting severe immune dysfunction in Ebola virus disease survivors 2020 Aurélie Wiedemann
Emile Foucat
Hakim Hocini
CĂ©cile Lefebvre
Boris P. Hejblum
MĂ©lany Durand
Miriam KrĂŒger
Alpha Kabinet KeĂŻta
Ahidjo Ayouba
Stéphane Mély
1
+ PDF Chat Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection 2021 David S. Khoury
Deborah Cromer
Arnold Reynaldi
Timothy E. Schlub
Adam K. Wheatley
Jennifer A. Juno
Kanta Subbarao
Stephen J. Kent
James A. Triccas
Miles P. Davenport
1
+ PDF Chat Ebola virus disease 2019 Denis Malvy
Anita K. McElroy
Hilde De Clerck
Stephan GĂŒnther
Johan van Griensven
1
+ Multivariate, Transgenerational Associations of the COVID-19 Pandemic Across Minoritized and Marginalized Communities 2022 Sarah W. Yip
Ayana Jordan
Robert Köhler
Avram J. Holmes
Danilo Bzdok
1
+ PDF Chat Addressing Vaccine Inequity — Covid-19 Vaccines as a Global Public Good 2022 David J. Hunter
Salim S. Abdool Karim
Lindsey R. Baden
Jeremy Farrar
Mary Beth Hamel
Dan L. Longo
Stephen Morrissey
Eric J. Rubin
1